USING THE filter

To help you find the relevant news, filter the list using the categories below.

 

MIRCA: An EDQM tool to enhance safe use of substances of human origin

EDQM 24/03/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) recently unveiled the Microbiological Risk of Contamination Assessment tool (dubbed “MiRCA”), which aims to improve the safety and efficacy of substances of human origin (SoHO) used for therapeutic purposes. The MiRCA tool,...

Read More

CEP 2.0 - Public consultation: CEP letter of access

EDQM 20/03/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) is seeking input from Certification of suitability (CEP) users for the implementation of the CEP 2.0

Read More

CEP 2.0: Use of EMA SPOR/OMS ORG_ID and LOC_ID mandatory for CEP applications

EDQM 20/03/2023 Strasbourg, France

As part of the implementation of the CEP 2.0, it will be mandatory as of 1 June 2023 to provide, in the application forms for new dossiers, sister files and revisions and renewals, the EMA SPOR/OMS ORG_ID and LOC_ID for all companies involved in Certification of suitability (CEP) dossiers....

Read More

Remote and online provision of medicines: EDQM targeted stakeholder consultation

EDQM 15/03/2023 STRASBOURG, FRANCE

From 13 March to 26 May 2023, the European Directorate for the Quality of Medicines & HealthCare (EDQM) is undertaking a targeted consultation to seek the opinions of interested parties on a draft Council of Europe recommendation on best practices for the remote and online provision of medicines....

Read More

Certification monthly report of activities: End of February 2023

EDQM 08/03/2023 strasbourg, france

The latest monthly activity report for the Certification of Substances Department (DCEP) is now available. End of February 2023 Certification Monthly Report For more information, access the Certification Database.

Read More

1 new Ph. Eur. reference standards and 15 replacement batches released in February 2023

EDQM 03/03/2023 Strasbourg, France

New Ph. Eur. reference standards Replacement batches for Ph. Eur. reference standards Removal Future removal Change of sales units Information on change of amount per unit Information on change of price Change of EDQM storage/shipping conditions See also: Content of the Ph. Eur. RS catalogue How...

Read More

European Pharmacopoeia Commission creates new Excipients Strategy Working Party

EDQM 03/03/2023 Strasbourg, France

During its 173rd session in June 2022, the European Pharmacopoeia Commission (EPC) approved the creation of a new Excipients Strategy Working Party (EXS) (see “Outcome of the 173rd session of the European Pharmacopoeia Commission, June 2022”). The EXS Working Party will focus on continuing to...

Read More

Pharmacopoeial Discussion Group achievements: sign-off on harmonisation texts

EDQM 28/02/2023 Strasbourg, France

As announced in the press release on 6 January 2023, the Pharmacopoeial Discussion Group (PDG) held its annual autumn meeting on 18-21 October 2022. In attendance were the three established members of the PDG – the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia (JP) and the United...

Read More

The future of pyrogenicity testing: new approaches discussed at joint EDQM-EPAA event

EDQM 27/02/2023 Brussels, Belgium

The European Directorate for the Quality of Medicines & HealthCare (EDQM) and the European Partnership for Alternative Approaches to Animal Testing (EPAA) have just held a highly successful three-day joint event aimed at phasing out the rabbit pyrogen test (RPT) from the testing of...

Read More

Independent control of COVID-19 vaccines: article co-authored by the EDQM and members of the OCABR Network published in npj Vaccines

EDQM 27/02/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) and members* of the Official Control Authority Batch Release (OCABR) Network of the General European OMCL Network (GEON) have co-authored an article entitled “Independent Control of COVID-19 Vaccines by EU Official Control...

Read More

International call for tenders for the provision of communication products and services (2023AO13)

EDQM 21/02/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM), a directorate of the Council of Europe, is launching an international call for tenders for the provision of communication products and services (2023AO13). Please find the link to the Tender file:...

Read More

Shutdown of European Pharmacopoeia 10th Edition

EDQM 14/02/2023 Strasbourg, France

The European Pharmacopoeia (Ph. Eur.) 10th Edition has been obsolete since 1 January 2023. Consequently, the 10th Edition online and all previous versions, including the Ph. Eur. archives for 10th Edition clients, have no longer been accessible since 31 January 2023. The Ph. Eur. 11th Edition and...

Read More

Public consultation on Ph. Eur. rabbit pyrogen test replacement texts in Pharmeuropa 35.1

EDQM 13/02/2023 Strasbourg, France

The European Pharmacopoeia (Ph. Eur.) has published the 59 texts (1 new general chapter, 5.1.13. Pyrogenicity, and 58 revised texts) concerned by the rabbit pyrogen test (RPT) replacement strategy for public consultation in Pharmeuropa 35.1, with a commenting deadline of 31 March 2023. These...

Read More

Ph. Eur. Commission establishes a dedicated working party on High Throughput Sequencing

EDQM 09/02/2023 Strasbourg, France

At its 174th session in November 2022, the European Pharmacopoeia (Ph. Eur.) Commission decided to create a new Working Party on High Throughput Sequencing (HTS), in charge of elaborating a general chapter on HTS for the detection of viral extraneous agents. Also known as NGS, this advanced...

Read More

24 replacement batches released in January 2023

03/02/2023 Strasbourg, France

Replacement batches for Ph. Eur. reference standards Removal Future removal Change of sales units Information on change of price Change of EDQM storage/shipping conditions See also: Content of the Ph. Eur. RS catalogue How to place an RS order   The European Directorate for the Quality of...

Read More

Certification monthly report of activities: End of January 2023

EDQM 03/02/2023 strasbourg, france

The latest monthly activity report for the Certification of Substances Department (DCEP) is now available. End of January 2023 Certification Monthly Report For more information, access the Certification Database.

Read More

Ph. Eur. launches public consultation on two chapters on pharmaceutical technology procedures

EDQM 01/02/2023 Strasbourg, France

The European Pharmacopoeia (Ph. Eur.) contains quality standards that are applied in a constantly evolving environment and it is therefore essential that its texts and the procedures they describe consistently reflect current practices. As is the case for any other text, where procedures relating...

Read More

SNOMED International and the EDQM collaborate on map development

EDQM 31/01/2023 Strasbourg, France

SNOMED International and the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, have signed an agreement governing the creation, maintenance and distribution of a map between both organisations’ terminologies. The agreement came into effect in September...

Read More

CEP holders – How to submit a nitrosamine risk assessment

EDQM 30/01/2023 Strasbourg, France

To facilitate the acceptance of proposed changes in a timely manner, the European Directorate for the Quality of Medicines & HealthCare (EDQM) would like to draw the attention of CEP holders to the following details regard minor revisions. Minor revisions should be submitted for revised...

Read More

European Paediatric Formulary: Simple syrup (preservative-free) monograph published

EDQM 25/01/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has added a new monograph, Simple syrup (preservative-free), to the European Paediatric Formulary. The monograph was published in Issue 4 of Pharmeuropa PaedForm in January 2022, approved by the European Pharmacopoeia...

Read More